Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.47%0700.HK-6.31%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.05%ORCL-0.97%3988.HK-0.76%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.70%0857.HK-1.46%UNH-10.21%1288.HK-1.78%PM-0.85%0005.HK-2.16%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.69%AUDUSD-1.58%AUDCAD-1.00%EURAUD+0.99%AUDCHF-0.99%GBPAUD+0.90%AUDNZD-0.87%NZDJPY-0.85%GBPJPY-0.80%EURJPY-0.73%NZDUSD-0.71%CADJPY-0.71%CHFJPY-0.70%GBPUSD-0.66%AUDSGD-0.63%USDCHF+0.62%EURUSD-0.60%USDCAD+0.59%AUDDKK-0.55%USDZAR+0.44%GBPTRY+0.41%USDMXN+0.41%USDNOK+0.35%USDTHB+0.35%AUDNOK-0.34%GBPHKD+0.32%NZDMXN+0.29%CHFNOK+0.29%GBPMXN-0.28%EURZAR+0.28%NOKJPY-0.28%USDSEK+0.24%GBPZAR+0.23%USDPLN+0.21%USDTRY+0.21%EURNOK+0.20%EURCNH-0.19%CHFSEK+0.18%EURHKD-0.17%USDILS+0.16%USDDKK+0.16%NZDCAD-0.14%USDJPY-0.14%GBPSGD-0.13%NZDCHF-0.13%PLNJPY-0.12%USDCNH-0.12%EURNZD+0.11%GBPCAD-0.09%EURSEK+0.09%EURSGD-0.08%EURGBP+0.07%USDSGD+0.07%EURPLN+0.05%GBPCHF-0.05%GBPNZD+0.05%EURCZK+0.04%USDCOP-0.04%NZDSGD-0.03%SGDJPY+0.02%CADCHF+0.02%EURCHF+0.02%USDHKD-0.02%EURCAD-0.01%CHFSGD0.00%EURDKK0.00%XPTUSD-1.21%XAGUSD-0.91%GAGUSD-0.90%W1-0.60%XAUUSD-0.59%GAUUSD-0.59%HG1-0.46%C1-0.40%XNGUSD-0.38%UKOIL+0.19%S1-0.19%COTTON-0.10%BTCUSD-3.68%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.67%ZECUSDT-7.18%XMRUSDT-2.30%DOGEUSD+55.95%LINKUSD-3.58%XLMUSD-3.94%BCHUSDT-3.64%LTCUSD+47.50%UNIUSD-3.23%SUIUSD-3.29%TONUSD+59.18%HBARUSDT-5.33%TAOUSDT-3.48%AAVEUSD-3.64%ONDOUSDT-5.58%ICPUSDT-2.22%DOTUSDT-4.03%WLDUSDT-3.94%ARBUSDT-5.88%ATOMUSDT-2.61%INJUSDT-8.05%STXUSDT-3.46%PYTHUSDT-1.30%TIAUSDT-3.37%FETUSDT-4.80%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.73%OPUSDT-3.90%IOTAUSDT-2.77%POLUSDT-2.01%WIFUSDT-2.98%AXSUSDT-3.20%EOSUSDT-4.46%IMXUSDT-4.36%FARTCOINUSDT-7.37%GALAUSDT-3.11%DYDXUSDT-3.12%ORDIUSDT-2.94%NOTUSDT-2.34%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.47%0700.HK-6.31%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.05%ORCL-0.97%3988.HK-0.76%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.70%0857.HK-1.46%UNH-10.21%1288.HK-1.78%PM-0.85%0005.HK-2.16%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.69%AUDUSD-1.58%AUDCAD-1.00%EURAUD+0.99%AUDCHF-0.99%GBPAUD+0.90%AUDNZD-0.87%NZDJPY-0.85%GBPJPY-0.80%EURJPY-0.73%NZDUSD-0.71%CADJPY-0.71%CHFJPY-0.70%GBPUSD-0.66%AUDSGD-0.63%USDCHF+0.62%EURUSD-0.60%USDCAD+0.59%AUDDKK-0.55%USDZAR+0.44%GBPTRY+0.41%USDMXN+0.41%USDNOK+0.35%USDTHB+0.35%AUDNOK-0.34%GBPHKD+0.32%NZDMXN+0.29%CHFNOK+0.29%GBPMXN-0.28%EURZAR+0.28%NOKJPY-0.28%USDSEK+0.24%GBPZAR+0.23%USDPLN+0.21%USDTRY+0.21%EURNOK+0.20%EURCNH-0.19%CHFSEK+0.18%EURHKD-0.17%USDILS+0.16%USDDKK+0.16%NZDCAD-0.14%USDJPY-0.14%GBPSGD-0.13%NZDCHF-0.13%PLNJPY-0.12%USDCNH-0.12%EURNZD+0.11%GBPCAD-0.09%EURSEK+0.09%EURSGD-0.08%EURGBP+0.07%USDSGD+0.07%EURPLN+0.05%GBPCHF-0.05%GBPNZD+0.05%EURCZK+0.04%USDCOP-0.04%NZDSGD-0.03%SGDJPY+0.02%CADCHF+0.02%EURCHF+0.02%USDHKD-0.02%EURCAD-0.01%CHFSGD0.00%EURDKK0.00%XPTUSD-1.21%XAGUSD-0.91%GAGUSD-0.90%W1-0.60%XAUUSD-0.59%GAUUSD-0.59%HG1-0.46%C1-0.40%XNGUSD-0.38%UKOIL+0.19%S1-0.19%COTTON-0.10%BTCUSD-3.68%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.67%ZECUSDT-7.18%XMRUSDT-2.30%DOGEUSD+55.95%LINKUSD-3.58%XLMUSD-3.94%BCHUSDT-3.64%LTCUSD+47.50%UNIUSD-3.23%SUIUSD-3.29%TONUSD+59.18%HBARUSDT-5.33%TAOUSDT-3.48%AAVEUSD-3.64%ONDOUSDT-5.58%ICPUSDT-2.22%DOTUSDT-4.03%WLDUSDT-3.94%ARBUSDT-5.88%ATOMUSDT-2.61%INJUSDT-8.05%STXUSDT-3.46%PYTHUSDT-1.30%TIAUSDT-3.37%FETUSDT-4.80%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.73%OPUSDT-3.90%IOTAUSDT-2.77%POLUSDT-2.01%WIFUSDT-2.98%AXSUSDT-3.20%EOSUSDT-4.46%IMXUSDT-4.36%FARTCOINUSDT-7.37%GALAUSDT-3.11%DYDXUSDT-3.12%ORDIUSDT-2.94%NOTUSDT-2.34%RONINUSDT-2.92%
BS

Bristol-Myers Squibb Company (BMY)

NYSE • Healthcare

$59.56
-$1.78 (-2.9%)
Market closed

November 18, 2026 at 21:00 UTC

Open$60.78
Day Range$59.48 - $61.18
Avg. Volume (3M)10.1M
Market Cap$121.7B
P/E Ratio13.2
52 Week Range
$45.27$68.64
Next EarningsIn 77 daysFeb 4, 2027

Interactive Chart

03:13:05 UTC

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$13B100%
Gross Profitminus cost of goods$8.9B68%
Operating Incomeminus R&D and overhead$2.8B22%
Net Incomeminus taxes and the rest$2.1B17%

In plain terms: out of every $100 in revenue, Bristol-Myers Squibb Company keeps $17 as net profit.

Fundamentals & Financials

Revenue (TTM)
$50B
Net Income (TTM)
$9.2B
EPS (TTM)
$4.52
ROA (TTM)
10.41%
Current Ratio
1.59
Dividend Yield
1.01%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+11.3%Q2 2026$1.58
+27.5%Q3 2026$2.04
+22.7%Q4 2026$1.35
Next

Feb 4

in 77 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +22.7%

Bristol-Myers Squibb beat expectations on both the top and bottom line in the third fiscal quarter of 2026, reported October 29, 2026, with adjusted EPS of $1.35 topping the $1.10 estimate (+22.7%) as revenue of $13.069 billion topped the $12.723 billion consensus (+2.7%). Revenue rose ~7% to about $13.1 billion (up from $12.222 billion a year ago), led by Net product sales, which increased ~6% to roughly $12.6 billion, while smaller lines were mixed, with Other revenues rising ~49% to about $368 million and Alliance revenues down ~24% to roughly $95 million. Profitability included gross profit of about $8.9 billion, translating to a gross margin of roughly 68%, and operating income of about $2.8 billion with operating margin near 22%. Net income edged down ~2% year over year to about $2.2 billion (from $2.201 billion), alongside adjusted EPS down ~17% from $1.63 a year ago despite the quarter’s consensus beat. The company generated operating cash flow of roughly $4.2 billion and paid about $1.3 billion in dividends. For the next period, consensus calls for EPS of $1.63 on revenue of $12.692 billion.

View full earnings history

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Company (NYSE: BMY) develops, manufactures, and sells prescription medicines as a large biopharmaceutical company in healthcare. Across hematology, cancer, cardiovascular, immune, neurological, fibrotic, and infectious-disease treatment areas, it generated $48.2 billion of revenue in FY2025 through a portfolio that spans oncology, immunology, and cardiovascular therapies.

Name
Bristol-Myers Squibb Company
CEO
Christopher Boerner
Industry
Healthcare
Year Founded
1887
Employees
32,500

Today's Snapshot

AI-generated

The day ended with BMY 2.9% lower at 59.56, in line with a weaker sector. Bristol-Myers Squibb raised its 2026 profit forecast.

Trading Volume

Above 10d avg 9.3M

9.5M

vs S&P 500 Today

Underperforming Market

-2.66%

Updated: November 18, 2026 at 21:25 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
BMY presents a cautious bearish picture with the stock around 59.56 while most short- and medium-term moving averages sit above the price, signaling near-term downward pressure. Momentum measures are negative and the CCI is deeply below zero, whereas MACD and RSI sit in neutral-to-weak territory, implying limited bullish conviction. Trend strength is low (ADX in the mid-teens), so the decline lacks conviction, and OBV shows net selling pressure on volume. Volatility is moderate per ATR, and classic pivots remain above the market. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$59.59 - $61.96
    Sell
  • RSI (14)40.87
    Neutral
  • Stochastic %K (14, 3, 3)26.19
    Neutral
  • MACD Level (12, 26)0.05
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.